| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dynactin binding | 5.94e-06 | 12 | 214 | 4 | GO:0034452 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | PLK2 ILK TRIO SRPK1 MAP3K5 MAP3K15 CAMK4 CAMK1G CSNK2A1 PRKACB PRKCG EIF2AK4 PRKDC PLK4 | 3.97e-05 | 363 | 214 | 14 | GO:0106310 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 4.45e-05 | 37 | 214 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | kinase binding | PLK2 ILK PIWIL1 CEACAM7 MAP3K5 IQGAP1 JUP PTPRR DLG2 PLA2G6 PLG ANK2 TTC28 TPRKB GOLGA6D XIAP UFL1 RHEB CCNA2 KIF20A LPA DNM3 AKAP11 CDC25B HTT | 4.45e-05 | 969 | 214 | 25 | GO:0019900 |
| GeneOntologyMolecularFunction | ATP-dependent protein binding | 1.88e-04 | 11 | 214 | 3 | GO:0043008 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.01e-04 | 188 | 214 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.15e-04 | 28 | 214 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | phospholipid binding | CEACAM7 NUP62 ATP8B1 IQGAP1 SYT5 PLA2G4F SNX11 ALDOB KIF16B APOB NISCH SBF2 WDFY3 AGAP9 MCTP2 VPS13B | 2.92e-04 | 548 | 214 | 16 | GO:0005543 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH8 ATP8B1 ABCD3 HFM1 ASCC3 DDX39B DYNC1H1 KIF16B NLRP1 ABCF2 KIF20A ABCB9 CCT8 DHX34 | 3.05e-04 | 441 | 214 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | PLK2 ILK TRIO SRPK1 MAP3K5 MAP3K15 CAMK4 CAMK1G CSNK2A1 PRKACB PRKCG EIF2AK4 PRKDC PLK4 | 3.41e-04 | 446 | 214 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH8 SETX ATP8B1 ABCD3 HFM1 ASCC3 DDX39B DYNC1H1 DNHD1 KIF16B NLRP1 ABCF2 KIF20A ABCB9 SMARCA2 CCT8 DHX34 | 3.50e-04 | 614 | 214 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | protein kinase binding | PLK2 ILK PIWIL1 CEACAM7 MAP3K5 IQGAP1 JUP PTPRR DLG2 PLA2G6 ANK2 TPRKB GOLGA6D XIAP UFL1 RHEB CCNA2 KIF20A DNM3 AKAP11 CDC25B | 4.75e-04 | 873 | 214 | 21 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase activity | PLK2 ILK TRIO SRPK1 MAP3K5 TYK2 DGUOK DLG2 MAP3K15 CAMK4 MAGI3 CAMK1G FRK CSNK2A1 PRKACB PRKCG EIF2AK4 PRKDC PLK4 | 5.96e-04 | 764 | 214 | 19 | GO:0016301 |
| GeneOntologyMolecularFunction | structural molecule activity | MYH8 MYL2 IMPG1 EVPL NUP62 COL25A1 JUP DLG2 IMPG2 COL6A3 KRT78 MXRA5 FMOD COL19A1 ANK2 TNC MRPS18B KRT23 POSTN DNM3 NUP93 | 6.19e-04 | 891 | 214 | 21 | GO:0005198 |
| GeneOntologyMolecularFunction | protein kinase activity | PLK2 ILK TRIO SRPK1 MAP3K5 TYK2 MAP3K15 CAMK4 CAMK1G FRK CSNK2A1 PRKACB PRKCG EIF2AK4 PRKDC PLK4 | 7.80e-04 | 600 | 214 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.12e-03 | 5 | 214 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | protein domain specific binding | VPS11 ILK INPP5D NUP62 MAP3K5 IQGAP1 PPP1R2B PTPN12 PPP1R2P1 DLG2 PLG NLRP1 CPE EBF1 CCNA2 RUFY2 PPP1R2 GUSB LPA PRKDC | 1.21e-03 | 875 | 214 | 20 | GO:0019904 |
| GeneOntologyBiologicalProcess | protein localization to centrosome | 4.36e-05 | 38 | 214 | 5 | GO:0071539 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 4.96e-05 | 39 | 214 | 5 | GO:1905508 | |
| GeneOntologyBiologicalProcess | dephosphorylation | INPP5D TSC1 IQGAP1 PPP1R2B PTPN12 PTPN13 PTPRR PPP1R2P1 OCRL PPP1R2 PPP1R16B CDC25B HTT | 7.28e-05 | 347 | 214 | 13 | GO:0016311 |
| GeneOntologyBiologicalProcess | tissue regeneration | 7.79e-05 | 99 | 214 | 7 | GO:0042246 | |
| GeneOntologyBiologicalProcess | growth | MYL2 ILK USP9X TRPC5 CEACAM7 GDF9 SESN1 IQGAP1 PTPN12 FLRT3 PLG DDX39B KPNA1 TNC GINS4 STIL PPARD OMG POSTN CSNK2A1 LPA FSHR SMARCA2 CCAR2 EIF2AK4 PRKDC LGR6 VPS13B | 8.30e-05 | 1235 | 214 | 28 | GO:0040007 |
| GeneOntologyBiologicalProcess | positive regulation of centriole replication | 8.83e-05 | 9 | 214 | 3 | GO:0046601 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 8.90e-05 | 136 | 214 | 8 | GO:0045445 | |
| GeneOntologyBiologicalProcess | cell growth | MYL2 ILK USP9X TRPC5 CEACAM7 GDF9 SESN1 IQGAP1 FLRT3 DDX39B TNC PPARD OMG POSTN CSNK2A1 SMARCA2 CCAR2 EIF2AK4 | 9.71e-05 | 625 | 214 | 18 | GO:0016049 |
| GeneOntologyBiologicalProcess | negative regulation of Rho guanyl-nucleotide exchange factor activity | 1.07e-04 | 2 | 214 | 2 | GO:2001107 | |
| GeneOntologyBiologicalProcess | neuron development | PLK2 RIPOR2 SETX ILK TRIO USP9X TRPC5 TSC1 ATP8B1 COL25A1 IQGAP1 DGUOK DLG2 FLRT3 TBCD SEMA3C TNC SYNE1 GOLGA6D OMG CRB1 POSTN IGF2BP1 PLXNC1 ZNF335 FSHR DNM3 EIF2AK4 LGR6 VPS13B HTT | 1.16e-04 | 1463 | 214 | 31 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of centriole replication | 1.41e-04 | 26 | 214 | 4 | GO:0046599 | |
| GeneOntologyCellularComponent | supramolecular fiber | VPS11 MYH8 MYL2 ILK INPP5D GDPD2 EVPL TSC1 IQGAP1 JUP SYNE2 DYNC1H1 TBCD COL6A3 KRT78 ANK2 SYNE1 KIF16B GOLGA6D PSTPIP2 KRT23 KIF20A FXR1 HOOK3 DNM3 CCT8 ZW10 | 8.26e-05 | 1179 | 215 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | VPS11 MYH8 MYL2 ILK INPP5D GDPD2 EVPL TSC1 IQGAP1 JUP SYNE2 DYNC1H1 TBCD COL6A3 KRT78 ANK2 SYNE1 KIF16B GOLGA6D PSTPIP2 KRT23 KIF20A FXR1 HOOK3 DNM3 CCT8 ZW10 | 9.24e-05 | 1187 | 215 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | centrosome | PLK2 USP9X TENT5C NUP62 EVI5 ALDOB DYNC1H1 TBCD BICD2 TTC28 STIL CCNA2 ORC2 HOOK3 PRKACB CCT8 AKAP11 NUP93 CDC25B PLK4 | 1.43e-04 | 770 | 215 | 20 | GO:0005813 |
| GeneOntologyCellularComponent | growth cone | SETX USP9X TRPC5 TSC1 IQGAP1 PPP1R2B PPP1R2P1 FLRT3 PPP1R2 IGF2BP1 | 2.35e-04 | 245 | 215 | 10 | GO:0030426 |
| GeneOntologyCellularComponent | site of polarized growth | SETX USP9X TRPC5 TSC1 IQGAP1 PPP1R2B PPP1R2P1 FLRT3 PPP1R2 IGF2BP1 | 3.04e-04 | 253 | 215 | 10 | GO:0030427 |
| GeneOntologyCellularComponent | postsynapse | TRIO USP9X TSC1 CSMD2 ITGB4 RTN1 PPP1R2B PPP1R2P1 DLG2 FLRT3 USP48 KPNA1 ANK2 CAMK4 SYNE1 RHEB TFR2 PPP1R2 IGF2BP1 FXR1 DNM3 PRKCG HTT | 3.46e-04 | 1018 | 215 | 23 | GO:0098794 |
| GeneOntologyCellularComponent | extracellular matrix | IMPG1 MMP27 COL25A1 ITGB4 FREM2 FLRT3 PLG IMPG2 COL6A3 SEMA3C MXRA5 FMOD COL19A1 TNC POSTN LPA LGR6 | 4.68e-04 | 656 | 215 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | IMPG1 MMP27 COL25A1 ITGB4 FREM2 FLRT3 PLG IMPG2 COL6A3 SEMA3C MXRA5 FMOD COL19A1 TNC POSTN LPA LGR6 | 4.84e-04 | 658 | 215 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | microtubule organizing center | PLK2 USP9X TENT5C NUP62 EVI5 ALDOB DYNC1H1 TBCD BICD2 TTC28 STIL CCNA2 ORC2 HOOK3 PRKACB CCT8 AKAP11 NUP93 CDC25B PLK4 HTT | 5.45e-04 | 919 | 215 | 21 | GO:0005815 |
| GeneOntologyCellularComponent | axon | SETX ILK USP9X TRPC5 TSC1 IQGAP1 PPP1R2B PPP1R2P1 DLG2 SYT5 FLRT3 DYNC1H1 PPP1R2 IGF2BP1 FXR1 SBF2 DNM3 PRKCG WDFY3 HTT | 9.20e-04 | 891 | 215 | 20 | GO:0030424 |
| Domain | ARM-like | RIPOR2 SETX USP9X USP9Y JUP PUM3 RIPOR1 TBCD KPNA1 LTN1 PRKDC WDFY3 HTT | 1.28e-05 | 270 | 211 | 13 | IPR011989 |
| Domain | Spectrin_repeat | 1.67e-05 | 29 | 211 | 5 | IPR002017 | |
| Domain | SPEC | 2.76e-05 | 32 | 211 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.76e-05 | 32 | 211 | 5 | IPR018159 | |
| Domain | ARM-type_fold | VPS11 RIPOR2 USP9X USP9Y JUP PUM3 RIPOR1 TBCD KPNA1 APOB LTN1 PRKDC WDFY3 HTT | 3.31e-05 | 339 | 211 | 14 | IPR016024 |
| Domain | Kinase-like_dom | PLK2 ILK TRIO SRPK1 MAP3K5 TYK2 PTPN13 MAP3K15 CAMK4 CAMK1G FRK CSNK2A1 PRKACB DNM3 PRKCG EIF2AK4 PRKDC PLK4 | 4.61e-05 | 542 | 211 | 18 | IPR011009 |
| Domain | P-loop_NTPase | MYH8 SETX IQGAP1 NWD2 DGUOK ABCD3 DLG2 HFM1 ASCC3 DDX39B DYNC1H1 DNHD1 KIF16B MAGI3 NLRP1 ABCF2 RHEB KIF20A ABCB9 SMARCA2 DNM3 AGAP9 DHX34 | 9.41e-05 | 848 | 211 | 23 | IPR027417 |
| Domain | Spectrin | 1.18e-04 | 23 | 211 | 4 | PF00435 | |
| Domain | - | 2.24e-04 | 222 | 211 | 10 | 1.25.10.10 | |
| Domain | PROTEIN_KINASE_ATP | PLK2 ILK TRIO SRPK1 MAP3K5 TYK2 MAP3K15 CAMK4 CAMK1G FRK CSNK2A1 PRKACB PRKCG EIF2AK4 PLK4 | 2.38e-04 | 459 | 211 | 15 | PS00107 |
| Domain | PROTEIN_KINASE_ST | PLK2 ILK TRIO SRPK1 MAP3K5 MAP3K15 CAMK4 CAMK1G CSNK2A1 PRKACB PRKCG EIF2AK4 PLK4 | 2.53e-04 | 362 | 211 | 13 | PS00108 |
| Domain | LRRNT | 3.24e-04 | 53 | 211 | 5 | PF01462 | |
| Domain | PL48 | 3.78e-04 | 3 | 211 | 2 | PF15903 | |
| Domain | FAM65_N | 3.78e-04 | 3 | 211 | 2 | IPR031780 | |
| Domain | FAM65 | 3.78e-04 | 3 | 211 | 2 | IPR026136 | |
| Domain | DUF4071 | 3.78e-04 | 3 | 211 | 2 | PF13281 | |
| Domain | DUF4071 | 3.78e-04 | 3 | 211 | 2 | IPR025136 | |
| Domain | Protein_kinase_ATP_BS | PLK2 SRPK1 MAP3K5 TYK2 MAP3K15 CAMK4 CAMK1G FRK CSNK2A1 PRKACB PRKCG EIF2AK4 PLK4 | 3.93e-04 | 379 | 211 | 13 | IPR017441 |
| Domain | Prot_kinase_dom | PLK2 ILK TRIO SRPK1 MAP3K5 TYK2 MAP3K15 CAMK4 CAMK1G FRK CSNK2A1 PRKACB PRKCG EIF2AK4 PLK4 | 4.64e-04 | 489 | 211 | 15 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | PLK2 ILK TRIO SRPK1 MAP3K5 TYK2 MAP3K15 CAMK4 CAMK1G FRK CSNK2A1 PRKACB PRKCG EIF2AK4 PLK4 | 5.05e-04 | 493 | 211 | 15 | PS50011 |
| Domain | - | ACAP1 ILK TRPC4 TRPC5 PLA2G6 ANK2 RFXANK PPP1R16B MPHOSPH8 AGAP9 | 5.37e-04 | 248 | 211 | 10 | 1.25.40.20 |
| Domain | Ankyrin_rpt-contain_dom | ACAP1 ILK TRPC4 TRPC5 PLA2G6 ANK2 RFXANK PPP1R16B MPHOSPH8 AGAP9 | 6.47e-04 | 254 | 211 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | ACAP1 ILK TRPC4 TRPC5 PLA2G6 ANK2 RFXANK PPP1R16B MPHOSPH8 AGAP9 | 6.47e-04 | 254 | 211 | 10 | PS50297 |
| Domain | KASH | 7.51e-04 | 4 | 211 | 2 | IPR012315 | |
| Domain | Sec63 | 7.51e-04 | 4 | 211 | 2 | PF02889 | |
| Domain | Sec63 | 7.51e-04 | 4 | 211 | 2 | SM00973 | |
| Domain | POLO_box | 7.51e-04 | 4 | 211 | 2 | PF00659 | |
| Domain | KASH | 7.51e-04 | 4 | 211 | 2 | PS51049 | |
| Domain | Sec63-dom | 7.51e-04 | 4 | 211 | 2 | IPR004179 | |
| Domain | KASH | 7.51e-04 | 4 | 211 | 2 | SM01249 | |
| Domain | KASH | 7.51e-04 | 4 | 211 | 2 | PF10541 | |
| Domain | POLO_BOX | 7.51e-04 | 4 | 211 | 2 | PS50078 | |
| Domain | Ser/Thr_kinase_AS | PLK2 ILK TRIO SRPK1 MAP3K5 MAP3K15 CAMK4 CAMK1G CSNK2A1 PRKACB PRKCG EIF2AK4 | 7.81e-04 | 357 | 211 | 12 | IPR008271 |
| Domain | S_TKc | PLK2 TRIO SRPK1 MAP3K5 MAP3K15 CAMK4 CAMK1G CSNK2A1 PRKACB PRKCG EIF2AK4 PLK4 | 8.20e-04 | 359 | 211 | 12 | SM00220 |
| Domain | Ankyrin_rpt | TRPM4 ACAP1 ILK TRPC4 TRPC5 PLA2G6 ANK2 RFXANK PPP1R16B MPHOSPH8 | 8.21e-04 | 262 | 211 | 10 | IPR002110 |
| Domain | LRRNT | 8.60e-04 | 98 | 211 | 6 | IPR000372 | |
| Domain | LRRNT | 8.60e-04 | 98 | 211 | 6 | SM00013 | |
| Domain | Ank | 1.18e-03 | 228 | 211 | 9 | PF00023 | |
| Domain | POLO_box_dom | 1.24e-03 | 5 | 211 | 2 | IPR000959 | |
| Pubmed | TRIO USP9X TRPC4 TSC1 RTN1 MAP3K5 IQGAP1 SYNE2 DLG2 DYNC1H1 GOLGB1 FERMT3 KPNA1 ANK2 SYNE1 GOLGA6D RHEB FXR1 HOOK3 CSNK2A1 NISCH PRKACB DNM3 CCT8 CCAR2 PRKCG WDFY3 | 8.56e-11 | 963 | 217 | 27 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PLK2 SETX ILK TRIO PSMD7 NUP62 JUP PTPN13 SYNE2 AP1M1 GOLGB1 KRT78 TTC28 MAGI3 XIAP STIL LPIN3 FXR1 PRKCG AKAP11 PLEKHM3 NUP93 CDC25B PC PLK4 | 2.19e-10 | 861 | 217 | 25 | 36931259 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | USP9X NUP62 NKRF IQGAP1 JUP SYNE2 ABCD3 EMG1 PUM3 ASCC3 DDX39B DYNC1H1 GOLGB1 KRT78 SYNE1 ABCF2 UFL1 IGF2BP1 FXR1 HOOK3 PRPF3 CSNK2A1 CCT8 CCAR2 PRKDC NUP93 | 1.59e-09 | 1024 | 217 | 26 | 24711643 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX ILK SRPK1 TSC1 PSMD7 NKRF IQGAP1 JUP PTPN12 ABCD3 AP1M1 PUM3 ASCC3 DDX39B DYNC1H1 KPNA1 NOB1 ABCF2 OCRL KIF20A FXR1 PRPF3 LTN1 SMARCA2 CCT8 CCAR2 PRKDC NUP93 WDFY3 DHX34 | 1.90e-09 | 1353 | 217 | 30 | 29467282 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | USP9X NUP62 NKRF ABCD3 SGO2 PUM3 ASCC3 DDX39B KPNA1 ABCF2 ZFC3H1 KIF20A FXR1 PRPF3 NISCH SMARCA2 NUP93 | 3.08e-09 | 440 | 217 | 17 | 34244565 |
| Pubmed | SRPK1 NKRF FAM186A GOLGB1 DNHD1 SYNE1 XIAP LPIN3 IGF2BP1 FXR1 ZNF335 PC VPS13B | 3.25e-09 | 234 | 217 | 13 | 36243803 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PLK2 NUP62 IQGAP1 SGO2 DDX39B DYNC1H1 TBCD KPNA1 BICD2 MRPS18B SYNE1 CCNA2 PPP1R2 KIF20A ORC2 IGF2BP1 PRPF3 SMARCA2 CCAR2 PRKDC NUP93 ZW10 TEN1 CDC25B PLK4 VPS13B | 1.86e-08 | 1155 | 217 | 26 | 20360068 |
| Pubmed | TSC1 RTN1 JUP PTPN13 SYNE2 ABCD3 SNX11 BCL2L13 GOLGB1 KIF16B GOSR2 RUFY2 NISCH AKAP11 PLEKHM3 ZW10 VPS13B | 2.27e-08 | 504 | 217 | 17 | 34432599 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SRPK1 EVPL NUP62 ITGB4 NKRF IQGAP1 JUP ABCD3 EMG1 AP1M1 PUM3 ASCC3 DDX39B DYNC1H1 KPNA1 SEMA3C KRT78 MRPS18B NOB1 ABCF2 ZFC3H1 FXR1 PRPF3 CSNK2A1 CCT8 PRKDC NUP93 | 2.54e-08 | 1257 | 217 | 27 | 36526897 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ILK USP9X SRPK1 TSC1 PSMD7 EIPR1 IQGAP1 JUP ABCD3 SGO2 RARS2 DYNC1H1 KPNA1 KRT78 MRPS18B UFL1 CRB1 PPP1R2 IGF2BP1 PRPF3 CSNK2A1 RFXANK CCAR2 AKAP11 NUP93 ZW10 CDC25B | 3.92e-08 | 1284 | 217 | 27 | 17353931 |
| Pubmed | SRPK1 PSMD7 NUP62 NKRF IQGAP1 EVI5 SYNE2 ABCD3 PUM3 RARS2 ASCC3 DYNC1H1 MRPS18B NOB1 ABCF2 UFL1 GOSR2 CCNA2 IGF2BP1 HOOK3 PRPF3 GUSB LTN1 CCT8 CCAR2 PRKDC NUP93 ZW10 | 1.09e-07 | 1440 | 217 | 28 | 30833792 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TSC1 PSMD7 NUP62 RTN1 NKRF PPP1R2B JUP PTPN12 PTPN13 ABCD3 GOLGB1 ANK2 CAMK4 XIAP OCRL RHEB ORC2 IGF2BP1 PRPF3 CCT8 PRKDC PC | 1.15e-07 | 934 | 217 | 22 | 33916271 |
| Pubmed | TRIO IQGAP1 ABCD3 AP1M1 PUM3 ABCF2 RHEB FXR1 CSNK2A1 PRKDC NUP93 | 1.25e-07 | 215 | 217 | 11 | 30462309 | |
| Pubmed | USP9X PSMD7 NUP62 NKRF IQGAP1 ABCD3 AP1M1 ASCC3 DDX39B DYNC1H1 UFL1 IGF2BP1 FXR1 CCT8 CCAR2 PRKDC NUP93 ZW10 | 1.28e-07 | 638 | 217 | 18 | 33239621 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 TRIO SLC35E2B ITGB4 MAP3K5 TYK2 PROM2 RIPOR1 PLA2G6 SNX11 BCL2L13 DYNC1H1 TBCD NOB1 LPIN3 MTHFR NISCH ZNF335 SBF2 PRKDC WDFY3 PC DHX34 HTT | 1.31e-07 | 1105 | 217 | 24 | 35748872 |
| Pubmed | TRIO USP9X TSC1 PSMD7 PTPN12 PTPN13 PTPRR SYNE2 ABCD3 KPNA1 PSTPIP2 PPP1R2 POSTN PRPF3 CSNK2A1 SBF2 LTN1 CCAR2 EIF2AK4 NUP93 CDC25B PC PLK4 | 2.07e-07 | 1049 | 217 | 23 | 27880917 | |
| Pubmed | Structural basis for regulation of protein phosphatase 1 by inhibitor-2. | 2.40e-07 | 3 | 217 | 3 | 17636256 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | TRPM4 VPS11 USP9X ATP8B1 LDAH C5 FLRT3 DDX39B GOLGB1 APOB GOSR2 RHEB RUFY2 FXR1 HOOK3 GUSB LTN1 CCAR2 PRKDC NUP93 WDFY3 ZW10 PC | 2.53e-07 | 1061 | 217 | 23 | 33845483 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | SRPK1 EVI5 ABCD3 MAP3K15 COL6A3 ABCF2 UFL1 CSNK2A1 CCAR2 MPHOSPH8 PRKDC | 2.57e-07 | 231 | 217 | 11 | 36597993 |
| Pubmed | ILK SRPK1 TSC1 JUP ABCD3 AP1M1 ASCC3 DYNC1H1 ABCF2 UFL1 RUFY2 FXR1 SBF2 EIF2AK4 PRKDC NUP93 PC | 2.79e-07 | 601 | 217 | 17 | 33658012 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | USP9X IQGAP1 ABCD3 AP1M1 DYNC1H1 MRPS18B RUFY2 IGF2BP1 CCT8 CCAR2 PRKDC NUP93 PC | 2.99e-07 | 344 | 217 | 13 | 36282215 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRIO USP9X PSMD7 NUP62 IQGAP1 JUP ABCD3 AP1M1 SGO2 PUM3 DDX39B DYNC1H1 DNHD1 SYNE1 XIAP ABCF2 UFL1 APOB IGF2BP1 FXR1 CSNK2A1 CCT8 CCAR2 MPHOSPH8 PRKDC NUP93 PC | 3.13e-07 | 1425 | 217 | 27 | 30948266 |
| Pubmed | IQCF5 MYH8 TSC1 PSMD7 NUP62 IQGAP1 FAM186A SYNE2 DLG2 ALAS2 DDX39B GOLGB1 ANK2 SYNE1 GOLGA6D MAGI3 ABCF2 APOB ZFC3H1 KRT23 FXR1 ABCB9 PRKACB CCAR2 MPHOSPH8 EIF2AK4 PRKDC | 3.94e-07 | 1442 | 217 | 27 | 35575683 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | NUP62 LDAH IQGAP1 ABCD3 AP1M1 PUM3 ASCC3 DDX39B DYNC1H1 KPNA1 MRPS18B IGF2BP1 FXR1 LTN1 SMARCA2 CCT8 PRKDC PC | 5.35e-07 | 704 | 217 | 18 | 29955894 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | TRIO SRPK1 ITGB4 IQGAP1 ASCC3 KRT78 LTN1 SMARCA2 EIF2AK4 PRKDC | 6.37e-07 | 202 | 217 | 10 | 33005030 |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | ILK USP9X USP9Y TPRKB CCNA2 PPP1R2 FRK CSNK2A1 PRKACB CCT8 AKAP11 PRKDC WDFY3 VPS13B | 6.59e-07 | 432 | 217 | 14 | 23455922 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TSC1 PSMD7 RTN1 NKRF SPTBN5 SYNE2 ABCD3 RARS2 BCL2L13 DDX39B GOLGB1 TTC28 LYRM4 MRPS18B SYNE1 KIF16B XIAP UFL1 OCRL GOSR2 IGF2BP1 FXR1 NISCH CCAR2 AKAP11 ZW10 VPS13B | 7.99e-07 | 1496 | 217 | 27 | 32877691 |
| Pubmed | PLK2 USP9X CEACAM7 MMP27 SRPK1 PLA2G4F BCL2L13 CAMK4 XIAP CAMK1G FRK CSNK2A1 PRKACB SMARCA2 PRKCG KDM1B CDC25B PLK4 | 8.99e-07 | 730 | 217 | 18 | 34857952 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ILK USP9X SRPK1 TSC1 IQGAP1 JUP SYNE2 ABCD3 EMG1 AP1M1 DDX39B DYNC1H1 GOLGB1 KPNA1 MRPS18B NOB1 ABCF2 UFL1 IGF2BP1 FXR1 PRPF3 CSNK2A1 CCT8 CCAR2 PRKDC PC | 9.35e-07 | 1415 | 217 | 26 | 28515276 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SRPK1 EVPL PSMD7 TYK2 PTPN12 PTPRR ABCD3 ASCC3 KPNA1 MRPS18B ABCF2 PSTPIP2 IGF2BP1 FXR1 CSNK2A1 LTN1 CCT8 CCAR2 PRKDC NUP93 CDC25B | 9.43e-07 | 974 | 217 | 21 | 28675297 |
| Pubmed | Cloning and characterization of human phosphatase inhibitor-2 (IPP-2) sequences. | 9.54e-07 | 4 | 217 | 3 | 7949733 | |
| Pubmed | Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease. | 9.54e-07 | 4 | 217 | 3 | 25351248 | |
| Pubmed | USP9X INPP5D USP9Y IQGAP1 PTPN12 DYNC1H1 KRT78 PSTPIP2 DNM3 CCT8 PRKDC | 1.03e-06 | 266 | 217 | 11 | 19380743 | |
| Pubmed | ACAP1 ILK USP9X PSMD7 ARL6IP1 ABCD3 AP1M1 ASCC3 DYNC1H1 GOLGB1 FERMT3 ABCF2 GOSR2 ORC2 FXR1 PLXNC1 GUSB NISCH PRKDC NUP93 ZW10 DHX34 MCTP2 | 1.31e-06 | 1168 | 217 | 23 | 19946888 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | TRIO USP9X IQGAP1 DLG2 DYNC1H1 ANK2 SYNE1 PRKACB PRKCG AKAP11 AGAP9 | 1.76e-06 | 281 | 217 | 11 | 28706196 |
| Pubmed | PLK2 TRIO USP9X PSMD7 USP9Y IQGAP1 PTPN13 DLG2 DYNC1H1 KPNA1 BICD2 ANK2 TTC28 SYNE1 MAGI3 ZFC3H1 TRIM52 RUFY2 NISCH PPP1R16B DNM3 PRKDC WDFY3 PC | 1.91e-06 | 1285 | 217 | 24 | 35914814 | |
| Pubmed | TRIO PTPN12 AP1M1 KPNA1 TTC28 GOLGA6D HOOK3 LTN1 CCT8 EIF2AK4 | 2.06e-06 | 230 | 217 | 10 | 35449600 | |
| Pubmed | TDRD15 SETX PSMD7 PTPN13 ABCD3 DYNC1H1 GOLGB1 TTC28 CAMK4 APOB OCRL CRB1 KIF20A IGF2BP1 CCT8 CCAR2 PRKDC PC | 2.17e-06 | 777 | 217 | 18 | 35844135 | |
| Pubmed | 2.37e-06 | 5 | 217 | 3 | 30144392 | ||
| Pubmed | Protein Phosphatase-1 Inhibitor-2 Is a Novel Memory Suppressor. | 2.37e-06 | 5 | 217 | 3 | 26558779 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRPM4 TRIO ATP8B1 EIPR1 SESN1 TYK2 PTPN13 PTPRR PROM2 RIPOR1 PLA2G6 ZNF107 GOLGB1 TBCD KPNA1 MAGI3 XIAP H6PD PRPF3 SBF2 PRKACB SMARCA2 EIF2AK4 MCTP2 VPS13B HTT | 2.38e-06 | 1489 | 217 | 26 | 28611215 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ACAP1 NKRF IQGAP1 JUP EMG1 DDX39B DYNC1H1 MRPS18B SYNE1 NOB1 ABCF2 APOB IGF2BP1 FXR1 PRPF3 CCT8 PRKDC NUP93 PC MCTP2 | 2.44e-06 | 949 | 217 | 20 | 36574265 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | ILK IQGAP1 TYK2 ABCD3 ASCC3 KPNA1 ABCF2 ZFC3H1 IGF2BP1 FXR1 PRPF3 CCT8 PRKDC PC | 2.61e-06 | 486 | 217 | 14 | 30940648 |
| Pubmed | TRPM4 SETX SRPK1 NUP62 NKRF IQGAP1 PTPN13 UBP1 ABCD3 EMG1 PUM3 ASCC3 GOLGB1 KPNA1 SEMA3C MRPS18B SYNE1 ABCF2 UFL1 ZFC3H1 CSNK2A1 LTN1 SMARCA2 CCT8 MPHOSPH8 KDM1B | 2.62e-06 | 1497 | 217 | 26 | 31527615 | |
| Pubmed | 2.70e-06 | 237 | 217 | 10 | 29564676 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SRPK1 PSMD7 NKRF ABCD3 AP1M1 ASCC3 DDX39B DYNC1H1 FERMT3 KPNA1 NOB1 ABCF2 UFL1 RHEB ORC2 IGF2BP1 FXR1 CSNK2A1 SMARCA2 CCT8 CCAR2 PRKDC NUP93 PC | 2.95e-06 | 1318 | 217 | 24 | 30463901 |
| Pubmed | USP9X CSMD2 DCUN1D4 UBP1 SYNE2 HFM1 C5 KPNA1 MXRA5 TTC28 TNC NOB1 KIF16B RHEB SMARCA2 WDFY3 | 2.99e-06 | 638 | 217 | 16 | 31182584 | |
| Pubmed | USP9X PTPN13 NWD2 ABCD3 DLG2 SYT5 TNC MAGI3 CPE FXR1 CSNK2A1 AGAP9 PC | 3.56e-06 | 430 | 217 | 13 | 32581705 | |
| Pubmed | SETX SRPK1 NKRF TYK2 FREM2 ABCD3 EMG1 AP1M1 SEMA3C TTC28 LPIN3 NISCH EIF2AK4 CDC25B DHX34 PLCE1 | 3.78e-06 | 650 | 217 | 16 | 38777146 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | ILK SRPK1 MAP3K5 TYK2 MAP3K15 TRIM2 CAMK4 CAMK1G PPARD FRK PRKACB PRKCG | 4.41e-06 | 372 | 217 | 12 | 22939624 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SETX ILK IQGAP1 USP48 DDX39B DYNC1H1 GOLGB1 KPNA1 PSTPIP2 ORC2 PRPF3 SMARCA2 CCT8 PRKDC NUP93 | 4.42e-06 | 582 | 217 | 15 | 20467437 |
| Pubmed | 4.73e-06 | 6 | 217 | 3 | 32414784 | ||
| Pubmed | TRIO SRPK1 ITGB4 QPCT PLA2G6 COL6A3 IQCH TTC28 NLRP1 APOB OMG IGF2BP1 CCAR2 PRKDC | 4.86e-06 | 513 | 217 | 14 | 25798074 | |
| Pubmed | 4.96e-06 | 313 | 217 | 11 | 20800603 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | PSMD7 NUP62 IQGAP1 JUP ABCD3 ASCC3 USP48 KPNA1 BICD2 TTC28 MAGI3 XIAP CCNA2 PRPF3 CSNK2A1 SMARCA2 EIF2AK4 NUP93 KDM1B CDC25B | 5.73e-06 | 1005 | 217 | 20 | 19615732 |
| Pubmed | RIPOR2 ITGB4 PTPN13 SYNE2 BCL2L13 DYNC1H1 TBCD PCDHB10 EBF1 PRKCG PRKDC | 6.48e-06 | 322 | 217 | 11 | 26514267 | |
| Pubmed | EVPL EVI5 EMG1 PLA2G6 ALAS2 USP48 GOLGB1 TRIM2 TNC MRPS18B UFL1 PSTPIP2 NPEPL1 CCNA2 POSTN ORC2 IGF2BP1 TTC23 GUSB NIPAL2 CCT8 MCTP2 PLK4 | 7.03e-06 | 1293 | 217 | 23 | 15342556 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TRIO TSC1 NUP62 IQGAP1 DYNC1H1 BICD2 TTC28 NOB1 MAGI3 XIAP OCRL STIL PPP1R2 HOOK3 PRKACB CCT8 NUP93 PC | 7.80e-06 | 853 | 217 | 18 | 28718761 |
| Pubmed | An Alternative Splicing Program for Mouse Craniofacial Development. | 8.12e-06 | 21 | 217 | 4 | 33013468 | |
| Pubmed | Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. | 8.23e-06 | 7 | 217 | 3 | 18689497 | |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 9.02e-06 | 77 | 217 | 6 | 24927568 | |
| Pubmed | ILK SRPK1 ITGB4 MAP3K5 TYK2 UBP1 ABCF2 ZFC3H1 CCNA2 CSNK2A1 CCT8 PRKDC | 9.40e-06 | 401 | 217 | 12 | 25852190 | |
| Pubmed | RIPOR2 TSC1 RIPOR1 DYNC1H1 BICD2 TTC28 SYNE1 NISCH DNM3 CCAR2 VPS13B PLCE1 | 1.09e-05 | 407 | 217 | 12 | 12693553 | |
| Pubmed | 1.09e-05 | 167 | 217 | 8 | 22159717 | ||
| Pubmed | 1.31e-05 | 8 | 217 | 3 | 36577382 | ||
| Pubmed | Primary cilia are WNT-transducing organelles whose biogenesis is controlled by a WNT-PP1 axis. | 1.31e-05 | 8 | 217 | 3 | 36693320 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ILK USP9X PSMD7 IQGAP1 JUP PTPN12 AP1M1 RIPOR1 USP48 DDX39B DYNC1H1 TBCD KPNA1 TPRKB GINS4 ABCF2 PPP1R2 CSNK2A1 PRKACB CCT8 CCAR2 PRKDC ZW10 HTT | 1.53e-05 | 1455 | 217 | 24 | 22863883 |
| Pubmed | MYH8 ILK TRIO MAP3K5 SYNE2 PUM3 COL6A3 ANK2 SYNE1 TPRKB ABCF2 HOOK3 PLCE1 | 1.66e-05 | 497 | 217 | 13 | 23414517 | |
| Pubmed | EVPL IQGAP1 JUP DDX39B DYNC1H1 GOLGB1 NPEPL1 PRPF3 PRKDC NUP93 PC | 1.83e-05 | 360 | 217 | 11 | 33111431 | |
| Pubmed | Comparative mapping of 50 human chromosome 9 loci in the laboratory mouse. | 2.03e-05 | 53 | 217 | 5 | 7774911 | |
| Pubmed | 2.47e-05 | 187 | 217 | 8 | 26460568 | ||
| Pubmed | 2.95e-05 | 312 | 217 | 10 | 37120454 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | SRPK1 NKRF IQGAP1 JUP PUM3 ASCC3 DDX39B KPNA1 KRT78 IGF2BP1 PRPF3 SMARCA2 CCAR2 PRKDC | 3.04e-05 | 605 | 217 | 14 | 28977666 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | USP9X SRPK1 IQGAP1 JUP ABCD3 AP1M1 TBCD NOB1 ABCF2 IGF2BP1 CSNK2A1 CCAR2 NUP93 PC | 3.15e-05 | 607 | 217 | 14 | 39147351 |
| Pubmed | USP9X SRPK1 PSMD7 IQGAP1 ABCD3 ASCC3 DDX39B KPNA1 MRPS18B NOB1 GINS4 ORC2 IGF2BP1 FXR1 MTHFR CSNK2A1 PRKACB CCT8 CCAR2 PRKDC NUP93 PC | 3.58e-05 | 1335 | 217 | 22 | 29229926 | |
| Pubmed | 3.74e-05 | 257 | 217 | 9 | 16335952 | ||
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 3.85e-05 | 258 | 217 | 9 | 21081666 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 21404224 | ||
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 3.88e-05 | 2 | 217 | 2 | 7705657 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 23041318 | ||
| Pubmed | Identification and characterization of two distinct PPP1R2 isoforms in human spermatozoa. | 3.88e-05 | 2 | 217 | 2 | 23506001 | |
| Pubmed | Divergent iron regulatory states contribute to heterogeneity in breast cancer aggressiveness. | 3.88e-05 | 2 | 217 | 2 | 39262774 | |
| Pubmed | Functional relationship among PLK2, PLK4 and ROCK2 to induce centrosome amplification. | 3.88e-05 | 2 | 217 | 2 | 25590559 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 6216475 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 11792814 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 18790697 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 25085631 | ||
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 3.88e-05 | 2 | 217 | 2 | 15456492 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 23702659 | ||
| Pubmed | A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes. | 3.88e-05 | 2 | 217 | 2 | 15601645 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 36109576 | ||
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 3.88e-05 | 2 | 217 | 2 | 22079981 | |
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 3.88e-05 | 2 | 217 | 2 | 9490683 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 16481742 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 18983515 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 11848464 | ||
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 3.88e-05 | 2 | 217 | 2 | 12895410 | |
| Pubmed | Incompatibility in cell adhesion constitutes a barrier to interspecies chimerism. | 3.88e-05 | 2 | 217 | 2 | 39181131 | |
| Pubmed | COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis. | 3.88e-05 | 2 | 217 | 2 | 27301070 | |
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 3.88e-05 | 2 | 217 | 2 | 21239499 | |
| Interaction | SIRT6 interactions | USP9X NUP62 NKRF ABCD3 SGO2 PUM3 ASCC3 USP48 DDX39B KPNA1 ABCF2 ZFC3H1 KIF20A FXR1 PRPF3 NISCH SMARCA2 CCT8 CCAR2 PRKDC NUP93 | 4.02e-06 | 628 | 215 | 21 | int:SIRT6 |
| GeneFamily | Ankyrin repeat domain containing | 1.02e-04 | 242 | 138 | 9 | 403 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.44e-04 | 4 | 138 | 2 | 1252 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SETX TRIO USP9X ATP8B1 DCUN1D4 EVI5 PTPN12 PTPN13 SYNE2 PUM3 ASCC3 SEMA3C TRIM2 TTC28 STIL ORC2 FXR1 CSNK2A1 LTN1 PRKACB SMARCA2 AKAP11 WDFY3 VPS13B PLCE1 | 4.77e-08 | 856 | 216 | 25 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | B3GALNT1 SETX USP9X COL25A1 PTPN13 SYNE2 PUM3 ZNF107 USP48 GOLGB1 SEMA3C TRIM2 FMOD KIF16B UFL1 FXR1 PLXNC1 SMARCA2 AKAP11 MPHOSPH8 | 5.84e-07 | 656 | 216 | 20 | M18979 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.28e-06 | 177 | 216 | 10 | M39245 | |
| Coexpression | GSE22886_TH1_VS_TH2_12H_ACT_UP | B3GALNT1 TRPM4 RIPOR2 KPNA1 BICD2 COL6A3 GSAP TFR2 CDC25B TLCD3A | 6.46e-06 | 199 | 216 | 10 | M4507 |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP | 6.46e-06 | 199 | 216 | 10 | M8401 | |
| Coexpression | GSE30083_SP1_VS_SP4_THYMOCYTE_DN | RIPOR2 TENT5C SESN1 MAP3K5 SYNE2 C5 PCED1B PLEKHM3 PRKDC MCTP2 | 6.75e-06 | 200 | 216 | 10 | M5030 |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 7.25e-06 | 86 | 216 | 7 | M39247 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 8.43e-06 | 162 | 216 | 9 | M45037 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | VPS11 RIPOR2 SETX USP9X TSC1 SESN1 MAP3K5 IQGAP1 EVI5 DGUOK SYNE2 ASCC3 DYNC1H1 KPNA1 LYRM4 MRPS18B TPRKB OCRL GOSR2 ZNF713 PLXNC1 LTN1 PRKACB PPP1R16B PRKDC PLK4 | 8.74e-06 | 1215 | 216 | 26 | M41122 |
| Coexpression | BROWNE_HCMV_INFECTION_12HR_DN | 1.96e-05 | 100 | 216 | 7 | M5775 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN | 3.39e-05 | 45 | 216 | 5 | M13714 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TRIO USP9X DCUN1D4 EVI5 PTPN12 PUM3 ASCC3 SEMA3C TRIM2 STIL ORC2 FXR1 PRKACB SMARCA2 | 3.57e-05 | 466 | 216 | 14 | M13522 |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN | 4.31e-05 | 199 | 216 | 9 | M3440 | |
| Coexpression | GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN | 4.31e-05 | 199 | 216 | 9 | M6507 | |
| Coexpression | GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN | 4.31e-05 | 199 | 216 | 9 | M4147 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 4.48e-05 | 200 | 216 | 9 | M9439 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | RIPOR2 INPP5D GSAP PSTPIP2 PRKACB PPP1R16B DNM3 AKAP11 WDFY3 | 4.48e-05 | 200 | 216 | 9 | M4456 |
| Coexpression | FIRESTEIN_PROLIFERATION | 7.39e-05 | 166 | 216 | 8 | M5354 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 9.66e-05 | 221 | 216 | 9 | M39222 | |
| Coexpression | TANG_SENESCENCE_TP53_TARGETS_DN | 9.85e-05 | 56 | 216 | 5 | M6171 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | SLC9A9 PLK2 INPP5D TRPC4 MMP27 SESN1 PTPN13 RIPOR1 MAP3K15 C5 BCL2L13 FERMT3 COL6A3 FMOD TTC28 TNC GSAP CCNA2 POSTN PLXNC1 GUSB FSHR RASGEF1B TEN1 | 9.86e-05 | 1242 | 216 | 24 | M1920 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP | 1.03e-04 | 174 | 216 | 8 | M8947 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | VPS11 ACAP1 RIPOR2 SETX USP9X INPP5D IQGAP1 GVINP1 AP1M1 ASCC3 DYNC1H1 TBCD FERMT3 BICD2 SYNE1 XIAP NLRP1 ZFC3H1 RHEB PCED1B PRKACB SMARCA2 PPP1R16B AKAP11 MPHOSPH8 CD96 VPS13B | 1.06e-04 | 1492 | 216 | 27 | M40023 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_EFFECTOR_T_CELL | 1.16e-04 | 132 | 216 | 7 | M39046 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | SRPK1 LDAH DGUOK EMG1 LYRM4 MRPS18B GINS4 ABCF2 CCNA2 KIF20A FXR1 CSNK2A1 RFXANK PRKDC NUP93 | 1.83e-04 | 612 | 216 | 15 | M4772 |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 2.04e-04 | 102 | 216 | 6 | M5601 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | EVPL ITGB4 IQGAP1 PTPN12 ARL6IP1 CCNA2 POSTN PRKACB PRKDC NUP93 CDC25B | 2.08e-04 | 359 | 216 | 11 | M15193 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 2.32e-04 | 196 | 216 | 8 | M5381 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | SLC9A9 PLK2 INPP5D TRPC4 MMP27 SESN1 PTPN13 RIPOR1 MAP3K15 C5 BCL2L13 FERMT3 COL6A3 FMOD TTC28 TNC GSAP CCNA2 POSTN PLXNC1 GUSB FSHR RASGEF1B TEN1 | 2.34e-04 | 1316 | 216 | 24 | MM1052 |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN | 2.44e-04 | 149 | 216 | 7 | M6683 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN | RIPOR2 NKRF IQGAP1 ABCD3 STIL CCNA2 PPP1R2 PRKDC CDC25B PLK4 | 2.48e-04 | 307 | 216 | 10 | M19745 |
| Coexpression | GSE360_CTRL_VS_T_GONDII_DC_DN | 2.49e-04 | 198 | 216 | 8 | M5148 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 2.58e-04 | 199 | 216 | 8 | M9443 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 2.58e-04 | 199 | 216 | 8 | M6646 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP | 2.66e-04 | 200 | 216 | 8 | M4622 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 2.66e-04 | 200 | 216 | 8 | M8030 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 2.66e-04 | 200 | 216 | 8 | M9354 | |
| Coexpression | GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN | 2.66e-04 | 200 | 216 | 8 | M8052 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN | 2.66e-04 | 200 | 216 | 8 | M8398 | |
| Coexpression | GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP | 2.66e-04 | 200 | 216 | 8 | M9696 | |
| Coexpression | GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP | 2.66e-04 | 200 | 216 | 8 | M9608 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN | 2.66e-04 | 200 | 216 | 8 | M3779 | |
| Coexpression | GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 2.66e-04 | 200 | 216 | 8 | M6057 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP | 2.66e-04 | 200 | 216 | 8 | M5072 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 2.86e-04 | 16 | 216 | 3 | M40964 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ACAP1 RIPOR2 INPP5D SYNE2 ZNF107 SYNE1 PRKACB LGR6 MCTP2 CD96 | 3.31e-08 | 190 | 216 | 10 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.83e-08 | 193 | 216 | 10 | 1b29525c5936d1b779253b8c20f059fa091c6127 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | ACAP1 TENT5C USP9Y SYNE2 CAMK4 SYNE1 PRKACB PPP1R16B CDC25B CD96 | 4.65e-08 | 197 | 216 | 10 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 |
| ToppCell | CTRL-Lymphoid|CTRL / Disease state, Lineage and Cell class | 3.03e-07 | 184 | 216 | 9 | 26fb2c4e6cb9950c27eb15428e7e74e5abb4397d | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.80e-07 | 189 | 216 | 9 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 3.80e-07 | 189 | 216 | 9 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-07 | 191 | 216 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | facs-Trachea-nan-3m-Lymphocytic-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-07 | 191 | 216 | 9 | c57df363e3a6e61d2bdca1955330f1899b964267 | |
| ToppCell | facs-Trachea-nan-3m-Lymphocytic|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-07 | 191 | 216 | 9 | 89eb4e30052d0d4a2952157ca743291900ce8de2 | |
| ToppCell | facs-Trachea-nan-3m-Lymphocytic-T_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-07 | 191 | 216 | 9 | 0bf575eba311745fb75f9523f7fc81f73848e25d | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-07 | 191 | 216 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-07 | 192 | 216 | 9 | 44cb225392c8d07150955ecf203fbdf6021c9790 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 4.34e-07 | 192 | 216 | 9 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | ACAP1 RIPOR2 INPP5D TENT5C SYNE2 CAMK4 SMARCA2 PPP1R16B CD96 | 4.34e-07 | 192 | 216 | 9 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.53e-07 | 193 | 216 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 4.53e-07 | 193 | 216 | 9 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.73e-07 | 194 | 216 | 9 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | Control-Lymphoid|Control / Disease state, Lineage and Cell class | 4.73e-07 | 194 | 216 | 9 | d5b124f15c953eeb7e8e990df44d7fa466f2b31f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-07 | 195 | 216 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-07 | 195 | 216 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | severe_COVID-19-CD8+_Tem|World / disease group, cell group and cell class (v2) | 5.16e-07 | 196 | 216 | 9 | f0d3067b0f596dd84da2af4bf062fb9f04ef1dc4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-07 | 197 | 216 | 9 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-07 | 197 | 216 | 9 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | severe_COVID-19-CD8+_Tem|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.61e-07 | 198 | 216 | 9 | 69d49f37cf5095e65c71cddc6d43748322ff19a3 | |
| ToppCell | Severe-Lymphoid|Severe / Condition, Lineage, Cell class and cell subclass | 5.85e-07 | 199 | 216 | 9 | 928e346b0f31d991ebab12fefb4eb9f4249e601d | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.10e-07 | 200 | 216 | 9 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.10e-07 | 200 | 216 | 9 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.64e-07 | 151 | 216 | 8 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 167 | 216 | 8 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 169 | 216 | 8 | 8f397cf4f9fd7c6fa88d01a95289ce2a6bc6938d | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 1.78e-06 | 169 | 216 | 8 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-06 | 175 | 216 | 8 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-06 | 175 | 216 | 8 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-06 | 175 | 216 | 8 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-06 | 175 | 216 | 8 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-06 | 175 | 216 | 8 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-06 | 175 | 216 | 8 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-06 | 178 | 216 | 8 | 65508833f9f7fb03d54b62cec9a1337a06b65031 | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 2.63e-06 | 178 | 216 | 8 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 180 | 216 | 8 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | Control-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 2.85e-06 | 180 | 216 | 8 | 47036eee4c128fbb443d1fc767b4de5cced93f0e | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.85e-06 | 180 | 216 | 8 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.97e-06 | 181 | 216 | 8 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 2.97e-06 | 181 | 216 | 8 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 2.97e-06 | 181 | 216 | 8 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Control / Disease state, Lineage and Cell class | 3.10e-06 | 182 | 216 | 8 | 31bb838cc2900f3c9da9f835d79d557a08abb928 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 183 | 216 | 8 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-06 | 184 | 216 | 8 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.36e-06 | 184 | 216 | 8 | f4c9272d5cc4a70df051413b5c60ca6d1d80eb84 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-06 | 184 | 216 | 8 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | IPF-Lymphoid-T_Regulatory|IPF / Disease state, Lineage and Cell class | 3.50e-06 | 185 | 216 | 8 | 221cbd09d94cc0947d0e3c1aa14716d17cb2068d | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 3.50e-06 | 185 | 216 | 8 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 3.50e-06 | 185 | 216 | 8 | 77fbecdab10bacc005b1c7e22ca414cfecef13c1 | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 3.78e-06 | 187 | 216 | 8 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-06 | 187 | 216 | 8 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 3.78e-06 | 187 | 216 | 8 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-06 | 187 | 216 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-06 | 187 | 216 | 8 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-06 | 187 | 216 | 8 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-06 | 188 | 216 | 8 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 3.94e-06 | 188 | 216 | 8 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-06 | 189 | 216 | 8 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 4.09e-06 | 189 | 216 | 8 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 4.26e-06 | 190 | 216 | 8 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 4.26e-06 | 190 | 216 | 8 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.26e-06 | 190 | 216 | 8 | e1b721bb74561fe51c53328a0394c9954e489049 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 4.26e-06 | 190 | 216 | 8 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 4.26e-06 | 190 | 216 | 8 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-06 | 190 | 216 | 8 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 191 | 216 | 8 | 92b2faa72c184b6ae49530fd3b50848510904997 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.42e-06 | 191 | 216 | 8 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.42e-06 | 191 | 216 | 8 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 191 | 216 | 8 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 191 | 216 | 8 | d0bbbf42d00165a53253c833adef65da6ec36bba | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.60e-06 | 192 | 216 | 8 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 192 | 216 | 8 | 1ee4783051ec94ea94600f040edcb385fc4289f1 | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 4.78e-06 | 193 | 216 | 8 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 4.78e-06 | 193 | 216 | 8 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 4.78e-06 | 193 | 216 | 8 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-06 | 193 | 216 | 8 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-06 | 193 | 216 | 8 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | COVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type | 4.78e-06 | 193 | 216 | 8 | 780e23e2705fc5c1b70e37568b79731ced5038bd | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.78e-06 | 193 | 216 | 8 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.15e-06 | 195 | 216 | 8 | ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.15e-06 | 195 | 216 | 8 | b8124e8a23e6d37b40023608674e67285c6ffe84 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-06 | 195 | 216 | 8 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-06 | 195 | 216 | 8 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.15e-06 | 195 | 216 | 8 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.15e-06 | 195 | 216 | 8 | 36c784709ee32174e05b457500339c3b8eee3244 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-06 | 195 | 216 | 8 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.15e-06 | 195 | 216 | 8 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 5.35e-06 | 196 | 216 | 8 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 5.35e-06 | 196 | 216 | 8 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.35e-06 | 196 | 216 | 8 | c4e7133c609bcbc48c4947ea0aa1a7d9d7251b04 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.35e-06 | 196 | 216 | 8 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.35e-06 | 196 | 216 | 8 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-06 | 196 | 216 | 8 | eb8c9a4a5eb21d43ff7b25deae5896c236f669b9 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.55e-06 | 197 | 216 | 8 | adc7bf2120fad4aea58123d882a8cf18ed4174d0 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.55e-06 | 197 | 216 | 8 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.55e-06 | 197 | 216 | 8 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; HL60; HT_HG-U133A | IMPG1 TRIO TRPC4 CEACAM7 SYT5 ALDOB TRIM2 H6PD MTHFR PPP1R16B DHX34 PLCE1 | 3.65e-07 | 196 | 214 | 12 | 2741_UP |
| Drug | NSC618487 | VPS11 MYL2 ILK PSMD7 MAP3K5 TYK2 PTPN13 DGUOK PLA2G6 BCL2L13 CAMK4 XIAP NLRP1 ABCF2 APOB CAMK1G CCNA2 FRK CSNK2A1 PRKACB IFNE PRKCG PRKDC PLK4 PLCE1 | 2.58e-06 | 933 | 214 | 25 | CID000005279 |
| Disease | glucose-dependent insulinotropic peptide measurement | 1.88e-06 | 53 | 206 | 6 | EFO_0008464 | |
| Disease | alkaline phosphatase measurement | TDRD15 ACAP1 CYP2B6 RIPOR2 NWD2 UBP1 PLA2G6 HFM1 USP48 ALDOB GOLGB1 TRIM2 KIF16B APOB EBF1 PPARD NPEPL1 FRK IGF2BP1 GUSB PLCE1 | 9.75e-06 | 1015 | 206 | 21 | EFO_0004533 |
| Disease | non-high density lipoprotein cholesterol measurement | TDRD15 PLK2 MYL2 ATP8B1 COL25A1 TYK2 EVI5 SYNE2 PLA2G6 HFM1 ASCC3 TRIM2 APOB FRK LPA DNM3 PLCE1 | 1.20e-05 | 713 | 206 | 17 | EFO_0005689 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.82e-05 | 222 | 206 | 9 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides in LDL measurement | 4.52e-05 | 56 | 206 | 5 | EFO_0022320 | |
| Disease | cholesterol to total lipids in large LDL percentage | 4.52e-05 | 56 | 206 | 5 | EFO_0022235 | |
| Disease | longevity, healthspan, parental longevity | 4.78e-05 | 29 | 206 | 4 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | biliary tract cancer (is_marker_for) | 4.85e-05 | 2 | 206 | 2 | DOID:4607 (is_marker_for) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 7.03e-05 | 99 | 206 | 6 | EFO_0004611, EFO_0007878 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 7.04e-05 | 12 | 206 | 3 | DOID:11726 (implicated_via_orthology) | |
| Disease | triglyceride measurement, alcohol consumption measurement | 7.86e-05 | 101 | 206 | 6 | EFO_0004530, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 8.30e-05 | 102 | 206 | 6 | EFO_0004329, EFO_0004611 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 8.64e-05 | 200 | 206 | 8 | EFO_0004611, EFO_0020945 | |
| Disease | total lipids in very large HDL measurement | 9.99e-05 | 66 | 206 | 5 | EFO_0022312 | |
| Disease | coronary artery disease | TDRD15 VPS11 MYL2 INPP5D C5 PLG USP48 TBCD SETD9 COL6A3 SEMA3C MAGI3 APOB GOSR2 IGF2BP1 MTHFR LPA ZNF335 RASGEF1B MCTP2 PLCE1 | 1.02e-04 | 1194 | 206 | 21 | EFO_0001645 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.07e-04 | 264 | 206 | 9 | EFO_0008317, EFO_0020944 | |
| Disease | cholesterol in very large HDL measurement | 1.24e-04 | 69 | 206 | 5 | EFO_0022229 | |
| Disease | response to statin, LDL cholesterol change measurement | 1.43e-04 | 15 | 206 | 3 | EFO_0007804, GO_0036273 | |
| Disease | Vitelliform macular dystrophy | 1.45e-04 | 3 | 206 | 2 | cv:C0339510 | |
| Disease | Adult-onset foveomacular vitelliform dystrophy | 1.45e-04 | 3 | 206 | 2 | cv:C1842914 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.89e-04 | 224 | 206 | 8 | EFO_0004530, EFO_0008317 | |
| Disease | myocardial infarction | 1.89e-04 | 350 | 206 | 10 | EFO_0000612 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.12e-04 | 17 | 206 | 3 | DOID:9884 (is_implicated_in) | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.12e-04 | 17 | 206 | 3 | EFO_0022232 | |
| Disease | Vitelliform Macular Dystrophy | 2.88e-04 | 4 | 206 | 2 | C0339510 | |
| Disease | Juvenile-Onset Vitelliform Macular Dystrophy | 2.88e-04 | 4 | 206 | 2 | C2745945 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 2.88e-04 | 4 | 206 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | periostin measurement | 2.88e-04 | 4 | 206 | 2 | EFO_0020628 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.88e-04 | 4 | 206 | 2 | cv:CN293514 | |
| Disease | Adult-Onset Vitelliform Macular Dystrophy | 2.88e-04 | 4 | 206 | 2 | C1842914 | |
| Disease | polyunsaturated fatty acid measurement | 3.26e-04 | 131 | 206 | 6 | EFO_0010733 | |
| Disease | total blood protein measurement | SLC35E2B MAP3K5 PTPRR ASCC3 IMPG2 EBF1 PPARD NPEPL1 FRK SBF2 PLCE1 | 3.42e-04 | 449 | 206 | 11 | EFO_0004536 |
| Disease | phosphoglycerides measurement | 3.53e-04 | 48 | 206 | 4 | EFO_0022291 | |
| Disease | Deep Vein Thrombosis | 4.06e-04 | 21 | 206 | 3 | C0149871 | |
| Disease | Venous Thrombosis | 4.06e-04 | 21 | 206 | 3 | C0042487 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 4.13e-04 | 50 | 206 | 4 | EFO_0022303 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 4.46e-04 | 51 | 206 | 4 | EFO_0022285 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 4.52e-04 | 91 | 206 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | Uterine leiomyoma | 4.52e-04 | 91 | 206 | 5 | HP_0000131 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 4.78e-04 | 5 | 206 | 2 | C0410190 | |
| Disease | tuberous sclerosis (implicated_via_orthology) | 4.78e-04 | 5 | 206 | 2 | DOID:13515 (implicated_via_orthology) | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 4.78e-04 | 5 | 206 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | vitelliform macular dystrophy (is_implicated_in) | 4.78e-04 | 5 | 206 | 2 | DOID:0050661 (is_implicated_in) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 4.78e-04 | 5 | 206 | 2 | C1450051 | |
| Disease | plasma plasminogen measurement | 4.78e-04 | 5 | 206 | 2 | EFO_0006309 | |
| Disease | hypertension, pregnancy-induced | 4.78e-04 | 5 | 206 | 2 | MONDO_0024664 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 4.90e-04 | 197 | 206 | 7 | EFO_0005680 | |
| Disease | total phospholipids in lipoprotein particles measurement | 5.17e-04 | 53 | 206 | 4 | EFO_0022315 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.60e-04 | 145 | 206 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ACAP1 TRPC4 ATP8B1 SYNE2 AP1M1 GOLGB1 COL19A1 ANK2 SYNE1 C1orf87 KIF16B H6PD FXR1 HOOK3 MTHFR NISCH LGR6 VPS13B | 5.71e-04 | 1074 | 206 | 18 | C0006142 |
| Disease | Coronary heart disease | 6.09e-04 | 24 | 206 | 3 | C0010068 | |
| Disease | lymphocyte count | ACAP1 PLK2 RIPOR2 MYL2 IQGAP1 TYK2 PTPN12 PDILT QPCT AP1M1 RIPOR1 PLA2G6 HFM1 FERMT3 TTC28 CAMK4 EBF1 PPARD TFR2 PPP1R2 HTT PLCE1 | 6.18e-04 | 1464 | 206 | 22 | EFO_0004587 |
| Disease | free cholesterol to total lipids in large HDL percentage | 6.38e-04 | 56 | 206 | 4 | EFO_0022279 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 6.64e-04 | 99 | 206 | 5 | EFO_0004574, EFO_0008595 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 6.69e-04 | 150 | 206 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | Emery-Dreifuss muscular dystrophy | 7.14e-04 | 6 | 206 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 7.14e-04 | 6 | 206 | 2 | C0410189 | |
| Disease | amphetamine abuse (implicated_via_orthology) | 7.14e-04 | 6 | 206 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | tendinitis (biomarker_via_orthology) | 7.14e-04 | 6 | 206 | 2 | DOID:971 (biomarker_via_orthology) | |
| Disease | thrombophilia (is_implicated_in) | 7.14e-04 | 6 | 206 | 2 | DOID:2452 (is_implicated_in) | |
| Disease | hemochromatosis (is_implicated_in) | 7.14e-04 | 6 | 206 | 2 | DOID:2352 (is_implicated_in) | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 7.14e-04 | 6 | 206 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | angiostatin measurement | 7.14e-04 | 6 | 206 | 2 | EFO_0008024 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.17e-04 | 152 | 206 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | low density lipoprotein particle size measurement | 7.29e-04 | 58 | 206 | 4 | EFO_0008593 | |
| Disease | sphingomyelin measurement | 7.91e-04 | 278 | 206 | 8 | EFO_0010118 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 8.29e-04 | 60 | 206 | 4 | EFO_0022282 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 8.30e-04 | 104 | 206 | 5 | EFO_0008591, EFO_0008595 | |
| Disease | triglycerides in small VLDL measurement | 8.82e-04 | 61 | 206 | 4 | EFO_0022145 | |
| Disease | free cholesterol in IDL measurement | 8.82e-04 | 61 | 206 | 4 | EFO_0022181 | |
| Disease | phospholipids in large VLDL measurement | 9.38e-04 | 62 | 206 | 4 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 9.38e-04 | 62 | 206 | 4 | EFO_0022322 | |
| Disease | peritonitis (biomarker_via_orthology) | 9.95e-04 | 7 | 206 | 2 | DOID:8283 (biomarker_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 9.95e-04 | 7 | 206 | 2 | C0751337 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 9.95e-04 | 7 | 206 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 9.96e-04 | 63 | 206 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 9.96e-04 | 63 | 206 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 9.96e-04 | 63 | 206 | 4 | EFO_0022239 | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 9.98e-04 | 162 | 206 | 6 | EFO_0004612, EFO_0007878 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 1.06e-03 | 64 | 206 | 4 | EFO_0022253 | |
| Disease | triglycerides in small LDL measurement | 1.12e-03 | 65 | 206 | 4 | EFO_0022323 | |
| Disease | lipoprotein A measurement | 1.16e-03 | 112 | 206 | 5 | EFO_0006925 | |
| Disease | phospholipids in very large HDL measurement | 1.19e-03 | 66 | 206 | 4 | EFO_0022298 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 1.20e-03 | 168 | 206 | 6 | EFO_0004329, EFO_0004612 | |
| Disease | serum alanine aminotransferase measurement | ATP8B1 PLA2G6 USP48 ALDOB BCL2L13 KRT78 KIF16B APOB PPARD FRK ZNF713 PRPF3 LTN1 HTT PLCE1 | 1.23e-03 | 869 | 206 | 15 | EFO_0004735 |
| Disease | Intellectual Disability | 1.26e-03 | 447 | 206 | 10 | C3714756 | |
| Disease | putamen volume | 1.31e-03 | 31 | 206 | 3 | EFO_0006932 | |
| Disease | Severe Congenital Microcephaly | 1.31e-03 | 31 | 206 | 3 | C3853041 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.32e-03 | 8 | 206 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | breast ductal carcinoma (is_marker_for) | 1.32e-03 | 8 | 206 | 2 | DOID:3007 (is_marker_for) | |
| Disease | free cholesterol in large VLDL measurement | 1.33e-03 | 68 | 206 | 4 | EFO_0022265 | |
| Disease | age at menopause | 1.34e-03 | 302 | 206 | 8 | EFO_0004704 | |
| Disease | cardiovascular disease | 1.48e-03 | 457 | 206 | 10 | EFO_0000319 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.51e-03 | 239 | 206 | 7 | EFO_0008317, EFO_0020945 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.56e-03 | 71 | 206 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | colorectal adenoma | 1.57e-03 | 33 | 206 | 3 | EFO_0005406 | |
| Disease | Microlissencephaly | 1.57e-03 | 33 | 206 | 3 | C1956147 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.65e-03 | 312 | 206 | 8 | EFO_0004612, EFO_0010351 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.71e-03 | 34 | 206 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.71e-03 | 34 | 206 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYLGLLSQEKLQEQH | 21 | Q9BXK5 | |
| QQDSGRLYLENKIHT | 821 | Q8N163 | |
| HFILELLQKEEYQGV | 46 | A0A1W2PQ73 | |
| YHTLNKLNLTEDIGQ | 26 | Q92564 | |
| KIGRYHQHLQEQLDL | 461 | Q9UG63 | |
| KNLQEINAYIGHSVE | 236 | P20813 | |
| YQDKVGLTHELVQSL | 106 | Q5VTM2 | |
| YGLAVLEEKHQLKLQ | 46 | Q8TD16 | |
| NIYNLIAIIRDQIKH | 626 | Q8TD16 | |
| KEDFHLLLQVYQITG | 3326 | Q7Z408 | |
| VLINLGLVYKVQQHN | 1311 | Q9P2K8 | |
| GVILFHETLYQKDSQ | 76 | P05062 | |
| HLEKNVNQSLLDLYQ | 106 | Q9BXU8 | |
| VDDETKLTLHGLQQY | 251 | Q13838 | |
| QQLQELNYKLELHSS | 1061 | Q6TFL3 | |
| ELYHLREKGNQSIEQ | 1286 | Q7Z2Y8 | |
| GTNLRKLYLQDNHIN | 246 | Q9NZU0 | |
| LQEYITQEGHKLETG | 131 | Q9BXS5 | |
| EKGIELAYLEQLHGQ | 211 | Q16854 | |
| VTDEYAGHLIQILKQ | 1341 | Q9UKA4 | |
| VGQQVHNLLLTYLIV | 151 | Q15041 | |
| YRKELGAQLHQLVLN | 216 | Q15027 | |
| NDAGIYTLHVIKENL | 116 | Q14002 | |
| GSIYLQRVQHKQLEQ | 491 | Q96M86 | |
| LNEQLGQIHYIFSDK | 441 | O43520 | |
| ETLLNHQDLGYQNEI | 361 | Q8N0U7 | |
| AKLEGVLAEVAQHYQ | 566 | P46940 | |
| YLLQNHLPTLLEEKQ | 911 | Q96L93 | |
| SQEIENHYIEGLGKQ | 331 | Q9ULI1 | |
| IYNEKIVNGHLQPNL | 191 | Q8N1F7 | |
| LSTIGYDNIIQHLNN | 16 | Q9H939 | |
| NLNKILQVFVLEYLH | 346 | Q16769 | |
| GLRIHIEKYLNVVNQ | 56 | Q86VS3 | |
| VEKVANGQYSHLVLL | 391 | Q15397 | |
| VTGNLDYKNLVHIIT | 146 | P10916 | |
| LVLSQHVKNDYLIGD | 776 | O94822 | |
| NHIDVVKYLLENGAN | 141 | Q01484 | |
| YSLEIEGNHLVQSKN | 41 | Q9H306 | |
| GELIQELIKNHKSTY | 791 | Q9BQK8 | |
| VNYHLVNVKGENITN | 536 | P42898 | |
| LEGLENLTALYLQHN | 196 | Q06828 | |
| VQLYDLGLQIHKDFL | 456 | P18428 | |
| RHAALQDIGKNIYTI | 16 | Q9ULX3 | |
| YQLEAEFVGVSHLKQ | 91 | Q9ULX3 | |
| LELGNDRLQTHTVYK | 536 | Q6DN12 | |
| IDHKLQQVIRDNLYL | 126 | Q5TCQ9 | |
| QGLQKGDIIKEIYHQ | 611 | Q5TCQ9 | |
| GDIIKEIYHQNVQNL | 616 | Q5TCQ9 | |
| QEKYLQALLNAVSVH | 1231 | Q86WG5 | |
| EGLHNLETLDLNYNK | 231 | Q9HBX8 | |
| LQVQGTKDISINIYH | 16 | Q17R60 | |
| KQILEAVAYLHENGI | 146 | Q16566 | |
| KESIGNVQVLLEYHI | 341 | P51114 | |
| ENDQVIVKIIGHFYA | 531 | Q9NZI8 | |
| LHYNEGLNIKLARQL | 146 | Q96PQ5 | |
| QYVHLGQEGIRDLIK | 1381 | Q5SZK8 | |
| NTGNLVKYLLNLNHS | 186 | O75752 | |
| QGQLLSIEHEVEAYK | 301 | Q9UQ16 | |
| YGEEQILQLHRTLQQ | 111 | Q86V42 | |
| YRNTQGILKETQLHL | 1646 | P13535 | |
| IISHELKGNINVSEY | 786 | O60486 | |
| DIHLLYSGKTVEINN | 326 | Q8NDH3 | |
| YLQTILKELQSGEHA | 101 | Q96HM7 | |
| DKLHGQVLSQEQYER | 1401 | Q9C000 | |
| TEIIDYNGNLHEALQ | 426 | Q9BXS0 | |
| QYIGELKDQIAELNH | 691 | O60447 | |
| EHNILQKEIDAYGQQ | 181 | Q92817 | |
| NNEYQVLLGIKTHLE | 351 | Q9C075 | |
| TKYQELQVSAQLHGD | 306 | Q8N1N4 | |
| LLQTVDGKHQDLKYI | 401 | P30305 | |
| YIGLVLLNDLHNFNE | 56 | Q9HCC8 | |
| DQLKYDVQHLQTALR | 71 | O14653 | |
| LHNQGIIYRDLKLDN | 471 | P05129 | |
| EELVKEQSGTIYLQH | 411 | P37198 | |
| NKQYLLLDSHTGNLL | 71 | Q9UN67 | |
| HLYSLADLQQVIEGK | 641 | Q6ZWE6 | |
| KGILDYNHEILGQQI | 81 | Q86VS8 | |
| QIHGAVKNVLELTLY | 101 | Q68DD2 | |
| QQLTHIELERLNYIG | 211 | Q0VAM2 | |
| LNEVYRQISGVHKLQ | 851 | P16144 | |
| FIEGHYELKENQLNI | 111 | A8MTL0 | |
| QLLKSAIVHLINYQD | 121 | P14923 | |
| LVGTQSLKYDNQIHI | 31 | Q53HC9 | |
| DLLLSKHGIYVQAIN | 491 | P22557 | |
| LHYNEGLNIKLARQL | 146 | P41236 | |
| NHSLDKGTLYIVEQI | 366 | Q6P4A8 | |
| QVLSAVKYLHENGIV | 126 | Q96NX5 | |
| DNYTIRNLVLKQGSH | 526 | Q15256 | |
| LIIGDADNQVVYLHK | 1031 | A2PYH4 | |
| LITVNGQEYHLQLVD | 46 | Q15382 | |
| HINLVKILVQYGADL | 146 | Q96T49 | |
| QAILTHSGKQYEVLN | 196 | Q9HB29 | |
| EYLQNDTGSKIHLTQ | 316 | P42685 | |
| LHVLNVERNGNIIYT | 46 | A4D1B5 | |
| VQFLEYELNVLGTHK | 3921 | P04114 | |
| HYTGLLKLQERVLNN | 896 | P42858 | |
| ENLLIDHQGYIQVTD | 171 | P22694 | |
| LEGQVLQFHLSNLEY | 531 | Q8NB78 | |
| ILRIEGHQLTYDNIN | 36 | Q14993 | |
| GHQLTYDNINKLEVS | 41 | Q14993 | |
| YGHLELIQLQLATQF | 511 | P08236 | |
| TDYQIKDGHVILQLN | 1451 | P01031 | |
| YQTKSDILGHLRQLQ | 696 | P12111 | |
| EIHKGKSYQLLVVEN | 241 | P10643 | |
| LLQYKADINAVNEHG | 86 | Q13418 | |
| NKNSLISYLEQIHRG | 361 | P16870 | |
| SYKVILGAHQEVNLE | 1871 | P08519 | |
| SEKTNNGIHYRLQLL | 101 | Q9UH73 | |
| HDNYDQLVRIAKVLG | 236 | P68400 | |
| HIGQLYSTDKLIIEN | 71 | Q9HD34 | |
| KVLQLYQITQINHGL | 2206 | Q14204 | |
| KDLAGRLQYSLQHIQ | 156 | P0CG33 | |
| GQKALLHYNEEAVQI | 136 | Q9NPA1 | |
| EKNLSQIENVHGYVL | 46 | Q15700 | |
| EHLLKSVLLYNINNS | 151 | O60383 | |
| QQLLGERNLLKEHYE | 841 | A6NE01 | |
| NLQYLLISNTGIKHL | 121 | P23945 | |
| VGEEYKLQNETLHLA | 221 | P20248 | |
| KLQNETLHLAVNYID | 226 | P20248 | |
| NLLGNDHIYNVIVTA | 46 | P00395 | |
| ELLSGYIHLSIQVNN | 536 | P82279 | |
| RVDHYLGKQAVAQIL | 201 | O95479 | |
| QYGNRILQTLKEHQV | 166 | Q14147 | |
| AVYSHVIQKLQLEGN | 276 | P20132 | |
| TEKFLIQLHQQLEYL | 106 | Q86WN2 | |
| QLYLTGVVVLHKDVN | 566 | O43395 | |
| NNVLVYDLLKNHLET | 711 | Q99549 | |
| IEGNLQLLDVIHYVN | 1921 | Q12923 | |
| VALGYRKVQQVIENH | 231 | O14593 | |
| NKQYLLLDSHTGNLL | 71 | Q9Y5E1 | |
| QILEGLKYLHDNQIV | 786 | Q99683 | |
| QILEGLKYLHENQIV | 756 | Q6ZN16 | |
| QQIIGQLSSLHNIYL | 406 | Q13416 | |
| LLEELGRKYQNHSTI | 426 | Q8N807 | |
| VGRLIDYIHKNDNVQ | 421 | Q96J94 | |
| KHQAQIDQYLGLVRT | 741 | Q16799 | |
| QQVADKHELGRLQYS | 101 | O00445 | |
| NLKEALGHQVIRINY | 156 | Q5T160 | |
| NHQNLLDSLEQYVKG | 1746 | Q93008 | |
| QGLQHFLEKVLQSVV | 101 | Q9Y5W9 | |
| VGQLIDEKFHIAYNL | 371 | Q9Y6P5 | |
| YHEQEQALQELGNKL | 501 | Q8WXA3 | |
| SALLINGTLKHYQLQ | 716 | P51531 | |
| IYVGSKDHILSLNIN | 66 | Q99985 | |
| NDQVTLLKYGVHEAI | 276 | Q03181 | |
| IGARQQQVTTYLHKD | 366 | Q9UKY4 | |
| KDEYQFQHQGAVELL | 11 | Q8IVB4 | |
| QRDYVIDLEKGSQHL | 191 | Q9BRT9 | |
| SELHTQLAKYQNILE | 4596 | Q8NF91 | |
| EQKLAVEISGNYQHL | 7476 | Q8NF91 | |
| VEISGNYQHLLEQQR | 7481 | Q8NF91 | |
| IHERLTQLELINKQY | 6186 | Q8WXH0 | |
| DGSQYINEKIKVLLH | 1126 | B5MCY1 | |
| DQLKQEGQVGHYELV | 671 | O15226 | |
| LHGIQLVALNYQTDD | 1806 | Q9P212 | |
| ATGKLPINHQIIYQL | 216 | P51665 | |
| YGLDKIEFLQSHENQ | 476 | P52294 | |
| EKEHLQQSYIDFGNI | 331 | Q9H841 | |
| AQLFEKQLQLYEIHG | 291 | Q05209 | |
| KQLQLYEIHGAQKIA | 296 | Q05209 | |
| YQDLLAVEHQGVKLL | 86 | Q8NE22 | |
| IKQQQYADLLSHDQL | 606 | Q92835 | |
| LKDLGVAYIAQVVNH | 421 | Q7Z333 | |
| NLYDSEIQNVLGVKH | 776 | Q562F6 | |
| SLYIVLGELQHQQDR | 71 | Q86WV5 | |
| TEIHEYNQDLIRKGQ | 666 | O60733 | |
| KIIQQVLQGLDYLHT | 191 | Q96SB4 | |
| SIHLLGKQYREELQD | 246 | Q9BZV3 | |
| SSYKVILGAHQEVNL | 631 | P00747 | |
| GNLQINAHLRKTTEY | 481 | O00444 | |
| SGLQENIIHLNLSYN | 51 | P23515 | |
| NGQYELIIQLHEKEQ | 36 | Q01968 | |
| LKNGLDEYLEVHQTE | 81 | Q9Y4F9 | |
| YQQQLEGALEIHVLS | 2356 | Q9NRC6 | |
| ILEQQRKLETYLQNH | 281 | Q5VWP2 | |
| ESEYLIQQAIHGNLQ | 676 | Q9NP78 | |
| VLKEYLDNVQLGHIL | 541 | P28288 | |
| TQGHDYVLAEKQVQR | 751 | Q8N3C0 | |
| GILQIEQESIHSKAY | 281 | Q96A61 | |
| TQAIQKARDHGLLIY | 151 | Q9Y676 | |
| KIYQDLLGQVNHLLN | 936 | Q15468 | |
| NLTTQKIIHTGENLY | 566 | Q9UII5 | |
| GEVNELYLEQLQNKH | 856 | Q92574 | |
| YQLKQHNILASVGED | 91 | Q9H270 | |
| LEQKGQEYINNIHLT | 331 | P98170 | |
| ALYIDGQLVNTVKLH | 1211 | Q8IZQ1 | |
| GIQTKIYNLLIQTHV | 126 | P40200 | |
| HLDINQYTNKLRQEL | 571 | Q8N271 | |
| LHYNEGLNIKLARQL | 146 | Q6NXS1 | |
| AEQYHTVLKLQGQVS | 811 | O95235 | |
| QQHTLLYKVNGILTL | 171 | Q8TBR7 | |
| GLLVVDNLQHLYNLV | 321 | Q9Y2I1 | |
| GQEYEISLHIVKNNT | 776 | P24821 | |
| TVGVLLYNKARQHQQ | 361 | P0CK96 | |
| ALQYHINKLSQSGEV | 296 | Q86UX7 | |
| LQDSLHQPQYVEKLE | 401 | O00507 | |
| ELKQHLNRTLAENYG | 121 | A1L157 | |
| NRAGLLQVYIHTQKN | 101 | Q92979 | |
| GELQKAILELHYSQE | 3071 | P78527 | |
| VKLHDETLTYLNQGQ | 76 | Q9NZI7 | |
| ERAKQYHEQQLGIAE | 451 | Q96AY4 | |
| IELKVVQHYIGQDGQ | 2741 | Q7Z7G8 | |
| AVQGLKQIHQQLYDR | 651 | Q9BTW9 | |
| LAEAHVNLAQGYLQL | 86 | Q5W5X9 | |
| YELIDVLVNNAKTHG | 1536 | Q6PGP7 | |
| GLLNLYVTNVKARHE | 581 | Q9UL62 | |
| NQENHKRYLGQVTLT | 156 | Q8N859 | |
| LRQIVSGLKYLHEQE | 186 | Q9NYY3 | |
| LEVNYGLKHKVLQSQ | 226 | Q9C040 | |
| NHILKVKVGLNELYN | 431 | Q15063 | |
| EYLQQLKQELGIELH | 566 | Q2TAA8 | |
| KRGLTAYLEVHQQEQ | 86 | Q6ZS17 | |
| NEVISKLYAVHQEGN | 461 | P50990 | |
| FYELELNIQGHKQLT | 236 | Q86UV5 | |
| QLQHQGIEYDVITLA | 1326 | Q9H4Z2 | |
| EVQILGDQYGNILHL | 246 | P11498 | |
| EDTYENLHKVLQGRL | 601 | Q9UP52 | |
| ALVALYLQTNQHDKA | 1641 | O60293 | |
| DLALKQLGHIREYEQ | 1156 | Q8TD43 | |
| HTNNYEIIKLLVQKG | 151 | Q9UBN4 | |
| HVQLVLGQLIDENYL | 106 | O94874 | |
| LTFDVIHQGQDLLQY | 841 | O75962 | |
| YLISQVEGHQVSLKN | 121 | Q9Y3C4 | |
| ALSYLENKNLVHGNV | 721 | P29597 | |
| LTIQKQNILYHLGEE | 166 | O43264 | |
| ITELHPLKAQLQEYQ | 2911 | Q14789 | |
| IKDIYGLNGQIEHKL | 106 | Q9H6V9 | |
| KQYHNLVSIINGETL | 2641 | Q9NR99 |